Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age (SORAML)

This study has been completed.
Information provided by (Responsible Party):
Technische Universität Dresden Identifier:
First received: May 4, 2009
Last updated: February 2, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
No publications provided by Technische Universität Dresden

Publications automatically indexed to this study by Identifier (NCT Number):